Artificial Intelligence
What Eight APAC Regulators Have Actually Published on AI in Drug Development
Ask a regulatory affairs lead in Tokyo, Seoul or Singapore what the rules are for using a machine learning model in a drug submission, and the honest answe...
October 21, 2026 | Analysis
NeuroXT Secures US FDA Clearance for AI-Powered Tool Predicting Alzheimer’s Dementia Progression
Supports clinicians in assessing progression from mild cognitive impairment to Alzheimer's dementia within five years NeuroXT Inc. to advance U.S. comme...
October 22, 2026 | News
CAS and Microsoft Bring Trusted Scientific Intelligence to Copilot to Accelerate Drug Discovery and R&D
CAS, a division of the American Chemical Society, announced the availability of CAS Connections in Microsoft Copilot. The connector gives Copilot customers...
October 22, 2026 | News
Insilico Medicine Hits First AI-Driven Oncology Milestone in $888 Million Servier Collaboration
Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. Insilico reach...
October 22, 2026 | News
Metabolon Launches AI-Enabled Splash & Ripple to Accelerate Metabolomics-Driven Drug Discovery
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpr...
October 22, 2026 | News
AstraZeneca and Oracle Join Forces to Harness AI and Real-World Data for Smarter Clinical Trials
Collaboration to connect AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities to accelera...
October 21, 2026 | News
Helfie AI Partners With Health Innovation South West to Advance Smartphone-Based Hypertension Screening
Helfie AI and UK-based Health Innovation South West have announced a partnership to explore how digital-first approaches to hypertension screening can supp...
October 20, 2026 | News
NTL HEALTHCARE Launches On-Premises AI Cervical Screening Platform to Strengthen Data Security
NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-powered cervical screeni...
October 19, 2026 | News
Danaher and NVIDIA Join Forces to Bring Autonomous AI-Powered Science into Laboratories
Danaher Corporation announced a collaboration with NVIDIA to advance autonomous science and help accelerate the pace of scientific discovery. As part of Da...
October 16, 2026 | News
Waters Partners with Anthropic to Advance AI-Driven Autonomous Laboratory Workflows
Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of de...
October 15, 2026 | News
Insilico Medicine Nominates AI-Designed VAV1 Molecular Glue Degrader for Autoimmune Diseases
VAV1 (Vav guanine nucleotide exchange factor 1) plays a key role in immune cell signaling pathways, holding immense potential in autoimmune disease interve...
October 15, 2026 | News
Suvoda Expands Sofia AI Assistant Across New Clinical Trials to Accelerate Study Operations
Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails. Sofia help...
October 13, 2026 | News
Helfie AI Partners With Kenya’s Homa Bay County to Pilot AI-Powered Health Screening for 100,000 People
Helfie AI ("Helfie"), an AI-powered preventive network transforming global healthcare, announced it has signed a Memorandum of Understanding (MOU) wi...
October 12, 2026 | News
GenScript and NVIDIA Launch Global PitchFest to Accelerate AI-Driven Drug Discovery Startups
GenScript Biotech Corporation announced the GenScript and NVIDIA Life Sciences Startup PitchFest, a global competition for startups applying arti...
October 12, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
